Track the Castle Biosciences, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1bn. The latest transaction was filed on 25 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Derek Maetzold. Every trade is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Castle Biosciences, Inc. Strong Buy (bullish), based on 9 analysts. Average price target: US$44.00.
33Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,564 of 29,064 companies
40.4
score / 100
Value
40
Quality
41
FCF yld2.8%
Earn yld-2.4%
EV/EBITDA·
ROE-4.2%
Gross mgn79%
Net mgn-7.0%
Debt/EBITDA3.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.